FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Federal Register Notices 7/3 to 7/10

FDA Webview posts the Federal Register notices published during our 7/3-10 annual Independence Day break.

latest-news-card-1
Medical Devices

CDRH Moving to Electronic Export Docs

CDRH says it is transitioning from paper export documents for medical devices to electronic export documents starting 1/2/2024.

latest-news-card-1
Human Drugs

Novartis Leqvio Gets Expanded Label

FDA approves a labeling update for Novartis Leqvio (inclisiran) to allow earlier use in patients with elevated LDL-C who have an increased risk of hea...

latest-news-card-1
Human Drugs

29-Page Intas FDA-483

FDA releases a 29-page form FDA-483 with 16 observations from a May inspection at Indias Intas Pharmaceuticals, a manufacturer of the oncology drug ci...

latest-news-card-1
Medical Devices

Outset Medical Gets Tablo Warning Letter

Outset Medical says it will cooperate with FDA in an effort to resolve a 7/5 Warning Letter about its Tablo Hemodialysis System.

latest-news-card-1
Biologics

Sarepta Sells Priority Voucher for $102 Million

Sarepta Therapeutics sells for $102 million its Rare Pediatric Disease Priority Review Voucher that was awarded last month.

latest-news-card-1
Human Drugs

Hemogenyx CAR-T Therapy on Clinical Hold

FDA issues Hemogenyx Pharmaceuticals a clinical hold on an IND for the companys chimeric antigen receptor T-cells therapy for treating acute myeloid l...

Medical Devices

Uniform AI/ML Marketing Guidelines Needed: Study

New York University researchers say more study is needed to develop uniform marketing guidelines for software-heavy medical devices that match their 5...

latest-news-card-1
Human Drugs

VCN-01 Orphan Status for Pancreatic Cancer

FDA grants Theriva Biologics an orphan drug designation for VCN-01, a systemic, selective, stroma-degrading oncolytic adenovirus for treating pancreat...

latest-news-card-1
Human Drugs

Madrigal Rolling NDA for Resmetirom

Madrigal Pharmaceuticals begins a rolling NDA submission seeking accelerated approval of resmetirom for treating nonalcoholic steatohepatitis.